A pilot trial of the anti-angiogenic copper lowering agent tetrathiomolybdate in combination with irinotecan, 5-flurouracil, and leucovorin for metastatic colorectal cancer.
一项关于抗血管生成降铜剂四硫钼酸盐与伊立替康、5-氟尿嘧啶和亚叶酸钙联合治疗转移性结直肠癌的试点试验
期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-008-9165-9
Gartner Elaina M, Griffith Kent A, Pan Quintin, Brewer George J, Henja Gwen F, Merajver Sofia D, Zalupski Mark M
